PTC THERAPEUTICS, INC. (PTCT) · INSIDERData sourcesSEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago
Public companyPTC THERAPEUTICS, INC.
PTCTCIK 0001070081
Price$65.44
1 year-8.8%
Disclosed transactions22
Buys / sells0 / 11
Max Insider Score27
Connections with evidence11
PTCT · disclosed activity on price
| Score | Actor | Security | Side | Value | Executed | Disclosed | Lag | Source | Evidence |
|---|
| 4 | KBKlein Matthew B.Director, CHIEF EXECUTIVE OFFICER | PTCTPTC THERAPEUTICS, INC. Open-market sale · 10b5-1 plan | SELL | $202K 2,850 sh | Apr 21, 2026 |
| Apr 23, 2026 traded Apr 21, 2026 |
| 8 | GSGolden Lee ScottEVP & CHIEF MEDICAL OFFICER | PTCTPTC THERAPEUTICS, INC. Open-market sale · 10b5-1 plan | SELL | $56K 829 sh | Apr 2, 2026 | Apr 6, 2026 traded Apr 2, 2026 | +4d | SEC Form 4 | |
| 11 | CCChutter Jessica CarolineDirector | PTCTPTC THERAPEUTICS, INC. Grant or award · 10b5-1 plan | A | — 3,333 sh | Mar 24, 2026 | Mar 26, 2026 traded Mar 24, 2026 | +2d | SEC Form 4 | |
| 0 | CCChutter Jessica CarolineDirector | PTCTPTC THERAPEUTICS, INC. Grant or award · 10b5-1 plan | A | — 2,896 sh | Mar 24, 2026 | Mar 26, 2026 traded Mar 24, 2026 | +2d | SEC Form 4 | |
| 0 | CCChutter Jessica CarolineDirector | PTCTPTC THERAPEUTICS, INC. Grant or award · 10b5-1 plan | A | — 4,000 sh | Mar 24, 2026 | Mar 26, 2026 traded Mar 24, 2026 | +2d | SEC Form 4 | |
| 0 | CCChutter Jessica CarolineDirector | PTCTPTC THERAPEUTICS, INC. Grant or award · 10b5-1 plan | A | — 3,475 sh | Mar 24, 2026 | Mar 26, 2026 traded Mar 24, 2026 | +2d | SEC Form 4 | |
| 4 | GPGravier PierreCHIEF FINANCIAL OFFICER | PTCTPTC THERAPEUTICS, INC. Open-market sale · 10b5-1 plan | SELL | $208K 2,992 sh | Feb 18, 2026 | Feb 20, 2026 traded Feb 18, 2026 | +2d | SEC Form 4 | |
| 14 | KBKlein Matthew B.Director, CHIEF EXECUTIVE OFFICER | PTCTPTC THERAPEUTICS, INC. Open-market sale · 10b5-1 plan | SELL | $192K 2,514 sh | Jan 8, 2026 | Jan 12, 2026 traded Jan 8, 2026 | +4d | SEC Form 4 | |
| 18 | UMUtter Christine MarieSVP, CHIEF ACCOUNTING OFFICER | PTCTPTC THERAPEUTICS, INC. Open-market sale · 10b5-1 plan | SELL | $79K 1,034 sh | Jan 8, 2026 | Jan 12, 2026 traded Jan 8, 2026 | +4d | SEC Form 4 | |
| 14 | KBKlein Matthew B.Director, CHIEF EXECUTIVE OFFICER | PTCTPTC THERAPEUTICS, INC. Open-market sale · 10b5-1 plan | SELL | $234K 3,016 sh | Jan 7, 2026 | Jan 8, 2026 traded Jan 7, 2026 | +1d | SEC Form 4 | |
| 18 | GPGravier PierreCHIEF FINANCIAL OFFICER | PTCTPTC THERAPEUTICS, INC. Open-market sale · 10b5-1 plan | SELL | $165K 2,139 sh | Jan 6, 2026 | Jan 8, 2026 traded Jan 6, 2026 | +2d | SEC Form 4 | |
| 17 | KBKlein Matthew B.Director, CHIEF EXECUTIVE OFFICER | PTCTPTC THERAPEUTICS, INC. Open-market sale · 10b5-1 plan | SELL | $396K 5,149 sh | Jan 6, 2026 | Jan 8, 2026 traded Jan 6, 2026 | +2d | SEC Form 4 | |
| 17 | GPGravier PierreCHIEF FINANCIAL OFFICER | PTCTPTC THERAPEUTICS, INC. Grant or award | A | — 20.0K sh | Jan 2, 2026 | Jan 6, 2026 traded Jan 2, 2026 | +4d | SEC Form 4 | |
| 9 | GPGravier PierreCHIEF FINANCIAL OFFICER | PTCTPTC THERAPEUTICS, INC. Grant or award | A | — 50.0K sh | Jan 2, 2026 | Jan 6, 2026 traded Jan 2, 2026 | +4d | SEC Form 4 | |
| 27 | KBKlein Matthew B.Director, CHIEF EXECUTIVE OFFICER | PTCTPTC THERAPEUTICS, INC. Open-market sale · 10b5-1 plan | SELL | $620K 8,089 sh | Dec 30, 2025 | Jan 2, 2026 traded Dec 30, 2025 | +3d | SEC Form 4 | |
| 0 | | PTCTPTC THERAPEUTICS, INC. Option exercise · 10b5-1 plan | M | — 10.0K sh | Nov 21, 2025 | Nov 25, 2025 traded Nov 21, 2025 | +4d | SEC Form 4 | |
| 19 | | PTCTPTC THERAPEUTICS, INC. Open-market sale · 10b5-1 plan | SELL | $795K 10.0K sh | Nov 21, 2025 | Nov 25, 2025 traded Nov 21, 2025 | +4d | SEC Form 4 | |
| 13 | | PTCTPTC THERAPEUTICS, INC. Option exercise · 10b5-1 plan | M | $512K 10.0K sh | Nov 21, 2025 | Nov 25, 2025 traded Nov 21, 2025 | +4d | SEC Form 4 | |
| 16 | | PTCTPTC THERAPEUTICS, INC. Gift | G | — 867 sh | Nov 20, 2025 | Nov 21, 2025 traded Nov 20, 2025 | +1d | SEC Form 4 | |
| 23 | | PTCTPTC THERAPEUTICS, INC. Open-market sale · 10b5-1 plan | SELL | $546K 7,333 sh | Nov 12, 2025 | Nov 14, 2025 traded Nov 12, 2025 | +2d | SEC Form 4 | |
| 0 | | PTCTPTC THERAPEUTICS, INC. Option exercise · 10b5-1 plan | M | — 7,333 sh | Nov 12, 2025 | Nov 14, 2025 traded Nov 12, 2025 | +2d | SEC Form 4 | |
| 17 | | PTCTPTC THERAPEUTICS, INC. Option exercise · 10b5-1 plan | M | $341K 7,333 sh | Nov 12, 2025 | Nov 14, 2025 traded Nov 12, 2025 | +2d | SEC Form 4 | |
EVP & CHIEF MEDICAL OFFICER · Apr 6, 2026